Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Compoundingcompoundingsynthetic peptidespcacfda

Analysis reviews PCAC recommendations on compounding synthetic peptides

International Journal of Pharmaceutical Compounding paper examines advisory committee guidance alongside industry safety standards for peptide compounding.

DO
By Daniel Okafor · Regulatory Correspondent
Jun 30 20:00 ETSource: International journal of pharmaceutical compounding

The wire

  1. 01Willis and Vu analyzed PCAC recommendations and industry safety standards for synthetic peptides in pharmacy compounding.
  2. 02Peptide compounding rules determine which products pharmacies can legally prepare.
  3. 03The excerpt does not detail specific peptides or regulatory conclusions.

From the source

Synthetic Peptides in Pharmacy Compounding: Analysis of PCAC Recommendations and Industry Safety Standards

International journal of pharmaceutical compounding · 2026 Jul-Aug · Willis J, Vu N et al.

Read at pubmed.ncbi.nlm.nih.gov
Source URL https://pubmed.ncbi.nlm.nih.gov/42752426/